Riesgo de diálisis según la ecuación de riesgo de insuficiencia renal (KFRE) en pacientes con enfermedad renal crónica inscritos en un programa de nefroprotección en La Guajira (Colombia) entre 2021 y 2023
| datacite.rights | http://purl.org/coar/access_right/c_16ec | spa |
| dc.contributor.advisor | Castillo Parodi, Luis | |
| dc.contributor.advisor | Conde Manotas, Juan | |
| dc.contributor.author | Chacón Buendía, Ernesto | |
| dc.date.accessioned | 2024-01-19T21:34:51Z | |
| dc.date.available | 2024-01-19T21:34:51Z | |
| dc.date.issued | 2023 | |
| dc.description.abstract | La Enfermedad Renal Crónica (ERC) es una condición progresiva y a largo plazo caracterizada por un deterioro gradual e irreversible de la función renal. En sus etapas iniciales, es un proceso lento y silencioso que conduce a una disminución en la tasa estimada de filtración glomerular (eGFR), una medida de la función renal. Objetivo: Evaluar el riesgo para requerir terapia de reemplazo renal según la Ecuación de Riesgo de Fallo Renal (KFRE, por sus siglas en inglés) en pacientes con Enfermedad Renal Crónica inscritos en un programa de nefroprotección en La Guajira (CO) entre los años 2021 y 2023. Métodos: Se realizó un estudio analítico, donde las variables se describieron de manera descriptiva en términos de medidas de tendencia central. Las variables cuantitativas fueron descritas y se utilizó la prueba t de Student o la prueba de Wilcoxon, según la normalidad de la variable. Por otro lado, se utilizó la prueba de Kruskal-Wallis para evaluar la función renal según las categorías de riesgo de ASCVD (Bajo, Moderado, Alto). Asimismo, se exploró la relación entre la albuminuria y la puntuación de riesgo de ASCVD mediante la correlación de Spearman. Para relacionar las categorías de riesgo de KFRE (Bajo, Moderado, Alto) y las categorías de riesgo de ASCVD (Bajo, Moderado, Alto), se realizó un análisis de correspondencia. Se aplicó la prueba exacta de Fisher o la prueba de Chi-cuadrado para analizar variables categóricas. El software estadístico utilizado fue R-CRAN versión 4.3.2. | spa |
| dc.description.abstract | Chronic Kidney Disease (CKD) is a progressive, long-term condition characterized by a gradual and irreversible deterioration of renal function. In its early stages, it is a slow and silent process, leading to a decrease in the estimated glomerular filtration rate (eGFR), a measure of kidney function. Therefore, the objective was to monitor the risk profiles for requiring renal replacement therapy according to the Kidney Failure Risk Equation (KFRE) in patients with chronic kidney disease enrolled in a nephroprotection program in La Guajira (CO) between the years 2021 and 2023. Methods: An analytical study was conducted, where variables were described descriptively in terms of central tendency measures. Quantitative variables were described, and either the Student's t-test or the Wilcoxon test was used, depending on the normality of the variable. On the other hand, the Kruskal-Wallis test was used to assess kidney function according to ASCVD risk categories (Low, Moderate, High). Likewise, the relationship between albuminuria and ASCVD risk score was explored through Spearman correlation. To relate KFRE risk categories (Low, Moderate, High) and ASCVD risk categories (Low, Moderate, High), a correspondence analysis was performed. The Fisher exact test or Chi-square test was applied to analyze categorical variables. The statistical software used was R-CRAN version 4.3.2. | eng |
| dc.format.mimetype | spa | |
| dc.identifier.uri | https://hdl.handle.net/20.500.12442/13828 | |
| dc.language.iso | spa | spa |
| dc.publisher | Ediciones Universidad Simón Bolívar | spa |
| dc.publisher | Facultad de Ciencias de la Salud | spa |
| dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 Internacional | eng |
| dc.rights.accessrights | info:eu-repo/semantics/restrictedAccess | spa |
| dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | |
| dc.subject | Enfermedad renal crónica | spa |
| dc.subject | Tasa de filtración glomerular | spa |
| dc.subject | Nefroprotección | spa |
| dc.subject | Riesgo cardiovascular | spa |
| dc.subject | Albuminuria | spa |
| dc.subject | Chronic Kidney Disease | eng |
| dc.subject | Glomerular filtration rate | eng |
| dc.subject | Nephroprotection | eng |
| dc.subject | Cardiovascular risk | eng |
| dc.title | Riesgo de diálisis según la ecuación de riesgo de insuficiencia renal (KFRE) en pacientes con enfermedad renal crónica inscritos en un programa de nefroprotección en La Guajira (Colombia) entre 2021 y 2023 | spa |
| dc.type.driver | info:eu-repo/semantics/other | spa |
| dc.type.spa | Otros | spa |
| dcterms.references | De Luis Román D, Bustamante J. Aspectos nutricionales en la insuficiencia renal. Nefrologia. 2008;28(3):333–42. | spa |
| dcterms.references | Gainza FJ. INSUFICIENCIA RENAL AGUDA. 2023;1–23. | spa |
| dcterms.references | Vaidya SR, Aeddula NR. Chronic Renal Failure. StatPearls. 2023. | eng |
| dcterms.references | Gyurászová M, Gurecká R, Bábíčková J, Tóthová Ľ. Oxidative Stress in the Pathophysiology of Kidney Disease: Implications for Noninvasive Monitoring and Identification of Biomarkers. Oxid Med Cell Longev. 2020;2020:5478708. | eng |
| dcterms.references | Rapa SF, Di Iorio BR, Campiglia P, Heidland A, Marzocco S. Inflammation and Oxidative Stress in Chronic Kidney Disease-Potential Therapeutic Role of Minerals, Vitamins and Plant-Derived Metabolites. Int J Mol Sci. 2019 Dec;21(1). | eng |
| dcterms.references | Panizo S, Martínez-Arias L, Alonso-Montes C, Cannata P, Martín-Carro B, Fernández-Martín JL, et al. Fibrosis in Chronic Kidney Disease: Pathogenesis and Consequences. Int J Mol Sci [Internet]. 2021 Jan 2;22(1). Available from: http://www.ncbi.nlm.nih.gov/pubmed/33401711 | spa |
| dcterms.references | Martens CR, Kirkman DL, Edwards DG. The Vascular Endothelium in Chronic Kidney Disease: A Novel Target for Aerobic Exercise. Exerc Sport Sci Rev. 2016 Jan;44(1):12–9. | eng |
| dcterms.references | Risso MA, Sallustio S, Sueiro V, Bertoni V, Gonzalez-Torres H, Musso CG. The Importance of Tubular Function in Chronic Kidney Disease. Int J Nephrol Renovasc Dis [Internet]. 2019 Dec;2019(12):257–62. Available from: https://www.dovepress.com/the-importance-of-tubular-function-in-chronic-kidney-disease-peer-reviewed-article-IJNRD | eng |
| dcterms.references | Ma K, Gao W, Xu H, Liang W, Ma G. Role and Mechanism of the Renin-Angiotensin-Aldosterone System in the Onset and Development of Cardiorenal Syndrome. J Renin Angiotensin Aldosterone Syst. 2022;2022:3239057. | eng |
| dcterms.references | Cabrera SS. Definición y clasificación de los estadios de la enfermedad renal crónica . Prevalencia . de riesgo de enfermedad renal crónica. NEFROLOGIA. 2004;24(6):27–34. | spa |
| dcterms.references | Chen TK, Knicely DH, Grams ME. Chronic Kidney Disease Diagnosis and Management: A Review. JAMA [Internet]. 2019 Oct 1;322(13):1294–304. Available from: http://www.ncbi.nlm.nih.gov/pubmed/31573641 | eng |
| dcterms.references | Nordheim E, Geir Jenssen T. Chronic kidney disease in patients with diabetes mellitus. Endocr Connect [Internet]. 2021 Apr 29;10(5):R151–9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/33830068 | eng |
| dcterms.references | Hovind P, Tarnow L, Rossing K, Rossing P, Eising S, Larsen N, et al. Decreasing incidence of severe diabetic microangiopathy in type 1 diabetes. Diabetes Care. 2003 Apr;26(4):1258–64. | eng |
| dcterms.references | Sica DA. The kidney and hypertension: causes and treatment. J Clin Hypertens (Greenwich). 2008 Jul;10(7):541–8. | eng |
| dcterms.references | Jara A, Mezzano S. [Vascular damage in chronic kidney disease]. Rev Med Chil. 2008 Nov;136(11):1476–84. | eng |
| dcterms.references | Taddei S, Nami R, Bruno RM, Quatrini I, Nuti R. Hypertension, left ventricular hypertrophy and chronic kidney disease. Heart Fail Rev. 2011 Nov;16(6):615–20. | eng |
| dcterms.references | Bidani AK, Griffin KA. Pathophysiology of Hypertensive Renal Damage. Hypertension. 2004 Nov;44(5):595–601. | eng |
| dcterms.references | Sun D, Wang J, Shao W, Wang J, Yao L, Li Z, et al. Pathogenesis and Damage Targets of Hypertensive Kidney Injury. J Transl Intern Med. 2020 Dec;8(4):205–9. | eng |
| dcterms.references | Akbar S, Bokhari SRA. Polycystic Kidney Disease. StatPearls. 2023. | eng |
| dcterms.references | Rishor-Olney CR, Hinson MR. Obstructive Uropathy. StatPearls. 2023. | eng |
| dcterms.references | Kazancioğlu R. Risk factors for chronic kidney disease: an update. Kidney Int Suppl. 2013 Dec;3(4):368–71. | eng |
| dcterms.references | Damtie S, Biadgo B, Baynes HW, Ambachew S, Melak T, Asmelash D, et al. Chronic Kidney Disease and Associated Risk Factors Assessment among Diabetes Mellitus Patients at A Tertiary Hospital, Northwest Ethiopia. Ethiop J Health Sci. 2018 Nov;28(6):691–700. | eng |
| dcterms.references | Thomas R, Kanso A, Sedor JR. Chronic kidney disease and its complications. Prim Care. 2008 Jun;35(2):329–44, vii. | eng |
| dcterms.references | Hashmi MF, Benjamin O, Lappin SL. End-Stage Renal Disease. StatPearls. 2023. | eng |
| dcterms.references | Pergola PE, Pecoits-Filho R, Winkelmayer WC, Spinowitz B, Rochette S, Thompson-Leduc P, et al. Economic Burden and Health-Related Quality of Life Associated with Current Treatments for Anaemia in Patients with CKD not on Dialysis: A Systematic Review. PharmacoEconomics - open. 2019 Dec;3(4):463–78. | eng |
| dcterms.references | Darlington O, Dickerson C, Evans M, McEwan P, Sörstadius E, Sugrue D, et al. Costs and Healthcare Resource Use Associated with Risk of Cardiovascular Morbidity in Patients with Chronic Kidney Disease: Evidence from a Systematic Literature Review. Adv Ther. 2021 Feb;38(2):994–1010. | eng |
| dcterms.references | Hull KL, Adenwalla SF, Topham P, Graham-Brown MP. Indications and considerations for kidney biopsy: an overview of clinical considerations for the non-specialist. Clin Med. 2022 Jan;22(1):34–40. | eng |
| dcterms.references | Pugh D, Gallacher PJ, Dhaun N. Management of Hypertension in Chronic Kidney Disease. Drugs. 2019 Mar;79(4):365–79. | eng |
| dcterms.references | Gounden V, Bhatt H, Jialal I. Renal Function Tests. StatPearls. 2023. | eng |
| dcterms.references | Adejumo OA, Okaka EI, Okwuonu CG, Iyawe IO, Odujoko OO. Serum C-reactive protein levels in pre-dialysis chronic kidney disease patientsin southern Nigeria. Ghana Med J. 2016 Mar;50(1):31–8. | eng |
| dcterms.references | Bouvet BR, Paparella C V., Arriaga SMM, Monje AL, Amarilla AM, Almará AM. Evaluation of urinary N-acetyl-beta-D-glucosaminidase as a marker of early renal damage in patients with type 2 diabetes mellitus. Arq Bras Endocrinol Metabol. 2014 Nov;58(8):798–801. | eng |
| dcterms.references | Madalena LB, Facio ML, Bresciani PD, Fraind SA, Alejandre ME, Pandolfo M, et al. Excreción de proteínas de bajo peso molecular en pacientes con proteinuria a cadena liviana como marcadoras de disfunción renal. Acta Bioquim Clin Latinoam. 2004;38(1):17–22. | spa |
| dcterms.references | Wu M-T, Lam K-K, Lee W-C, Hsu K-T, Wu C-H, Cheng B-C, et al. Albuminuria, proteinuria, and urinary albumin to protein ratio in chronic kidney disease. J Clin Lab Anal. 2012 Feb;26(2):82–92 | eng |
| dcterms.references | Moreno JA, Sevillano Á, Gutiérrez E, Guerrero-Hue M, Vázquez-Carballo C, Yuste C, et al. Glomerular Hematuria: Cause or Consequence of Renal Inflammation? Int J Mol Sci. 2019 May;20(9). | eng |
| dcterms.references | Inoue K, Streja E, Tsujimoto T, Kobayashi H. Urinary albumin-to-creatinine ratio within normal range and all-cause or cardiovascular mortality among U.S. adults enrolled in the NHANES during 1999-2015. Ann Epidemiol. 2021 Mar;55:15–23. | eng |
| dcterms.references | Shaikh H, Hashmi MF, Aeddula NR. Anemia of Chronic Renal Disease [Internet]. StatPearls. 2023. Available from: http://www.ncbi.nlm.nih.gov/pubmed/4975372 | eng |
| dcterms.references | Arnold R, Issar T, Krishnan A V, Pussell BA. Neurological complications in chronic kidney disease. JRSM Cardiovasc Dis [Internet]. 2016;5:2048004016677687. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27867500 | eng |
| dcterms.references | Kaw D, Malhotra D. Platelet dysfunction and end-stage renal disease. Semin Dial [Internet]. 2006;19(4):317–22. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16893410 | eng |
| dcterms.references | Espi M, Koppe L, Fouque D, Thaunat O. Chronic Kidney Disease-Associated Immune Dysfunctions: Impact of Protein-Bound Uremic Retention Solutes on Immune Cells. Toxins (Basel) [Internet]. 2020 May 6;12(5). Available from: http://www.ncbi.nlm.nih.gov/pubmed/32384617 | eng |
| dcterms.references | Fevrier-Paul A, Soyibo AK, Mitchell S, Voutchkov M. Role of Toxic Elements in Chronic Kidney Disease. J Heal Pollut [Internet]. 2018 Dec;8(20):181202. Available from: http://www.ncbi.nlm.nih.gov/pubmed/30560001 | eng |
| dcterms.references | Warrens H, Banerjee D, Herzog CA. Cardiovascular Complications of Chronic Kidney Disease: An Introduction. Eur Cardiol [Internet]. 2022 Feb;17:e13. Available from: http://www.ncbi.nlm.nih.gov/pubmed/35620357 | eng |
| dcterms.references | Sahadevan M, Kasiske BL. Hyperlipidemia in kidney disease: causes and consequences. Curr Opin Nephrol Hypertens [Internet]. 2002 May;11(3):323–9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/11981263 | eng |
| dcterms.references | Spoto B, Pisano A, Zoccali C. Insulin resistance in chronic kidney disease: a systematic review. Am J Physiol Renal Physiol [Internet]. 2016 Dec 1;311(6):F1087–108. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27707707 | eng |
| dcterms.references | Rosenstein K, Tannock LR. Dyslipidemia in Chronic Kidney Disease [Internet]. Endotext. 2000. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23067652 | eng |
| dcterms.references | Dialysis in chronic kidney disease [Internet]. Institute for Quality and Efficiency in Health Care (IQWIG). Colonia, Alemania; 2018. Available from: //www.ncbi.nlm.nih.gov/books/NBK492979/ | eng |
| dcterms.references | Carminatti M, Tedesco-Silva H, Silva Fernandes NM, Sanders-Pinheiro H. Chronic kidney disease progression in kidney transplant recipients: A focus on traditional risk factors. Nephrology (Carlton) [Internet]. 2019 Feb;24(2):141–7. Available from: http://www.ncbi.nlm.nih.gov/pubmed/30159972 | eng |
| dcterms.references | Ghanta M, Jim B. Renal Transplantation in Advanced Chronic Kidney Disease Patients. Med Clin North Am [Internet]. 2016 May;100(3):465–76. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27095639 | eng |
| dcterms.references | Hole B, Hemmelgarn B, Brown E, Brown M, McCulloch MI, Zuniga C, et al. Supportive care for end-stage kidney disease: an integral part of kidney services across a range of income settings around the world. Kidney Int Suppl [Internet]. 2020 Mar;10(1):e86–94. Available from: http://www.ncbi.nlm.nih.gov/pubmed/32149013 | eng |
| dcterms.references | Sultan S, Nasir K, Qureshi R, Dhrolia M, Ahmad A. Assessment of the Nutritional Status of the Hemodialysis Patients by Anthropometric Measurements. Cureus [Internet]. 2021 Oct;13(10):e18605. Available from: http://www.ncbi.nlm.nih.gov/pubmed/34765364 | eng |
| dcterms.references | Lordsleem A, Gueiros APS, Gueiros JE de B, Markman Filho B, Victor EG. Cardiac evaluation of patients with chronic kidney disease: what lessons? J Bras Nefrol [Internet]. 2012 Mar;34(1):8–15. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22441176 | eng |
| dcterms.references | McKercher CM, Venn AJ, Blizzard L, Nelson MR, Palmer AJ, Ashby MA, et al. Psychosocial factors in adults with chronic kidney disease: characteristics of pilot participants in the Tasmanian Chronic Kidney Disease study. BMC Nephrol [Internet]. 2013 Apr 12;14:83. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23586969 | eng |
| dcterms.references | Ahmed S, Mothi SS, Sequist T, Tangri N, Khinkar RM, Mendu ML. The Kidney Failure Risk Equation Score and CKD Care Delivery Measures: A Cross-sectional Study. Kidney Med [Internet]. 2022 Jan;4(1):100375. Available from: http://www.ncbi.nlm.nih.gov/pubmed/35072040 | eng |
| dcterms.references | Felipe Inserra, María Lía Torres, Alberto Alles CB. Evaluación de la función renal para la detección y seguimiento de la enfermedad renal crónica. Documento multidisciplinario de consenso 2021. Especial atención sobre situaciones clínicas específicas. FABA. 2022;56. | spa |
| dcterms.references | Gómez-Carracedo A, Arias-Muñana E, Jiménez-Rojas C. Enfermedad renal crónica - Progesión de la IRC. Nefrol al dia [Internet]. 2016;36(1):[48-55]. Available from: https://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S0211-69952016000500048&lng=es&nrm=iso&tlng=es | eng |
| dcterms.references | Kwek JL, Pang HQJ, Li H, Lim WWL, Choo JCJ, Choong HL, et al. Validation of the kidney failure risk equation in predicting the risk of progression to kidney failure in a multi-ethnic Singapore chronic kidney disease cohort. Singapore Med J [Internet]. 2022 Jun;63(6):313–8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/36043308 | eng |
| dcterms.references | Grams ME, Brunskill NJ, Ballew SH, Sang Y, Coresh J, Matsushita K, et al. The Kidney Failure Risk Equation: Evaluation of Novel Input Variables including eGFR Estimated Using the CKD-EPI 2021 Equation in 59 Cohorts. J Am Soc Nephrol [Internet]. 2023 Mar 1;34(3):482–94. Available from: http://www.ncbi.nlm.nih.gov/pubmed/36857500 | eng |
| dcterms.references | Hundemer GL, Tangri N, Sood MM, Ramsay T, Bugeja A, Brown PA, et al. Performance of the Kidney Failure Risk Equation by Disease Etiology in Advanced CKD. Clin J Am Soc Nephrol. 2020 Oct;15(10):1424–32. | eng |
| dcterms.references | Matsushita K, Mahmoodi BK, Woodward M, Emberson JR, Jafar TH, Jee SH, et al. Comparison of risk prediction using the CKD-EPI equation and the MDRD study equation for estimated glomerular filtration rate. JAMA [Internet]. 2012 May 9;307(18):1941–51. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22570462 | eng |
| dcterms.references | Coca SG, Zabetian A, Ferket BS, Zhou J, Testani JM, Garg AX, et al. Evaluation of Short-Term Changes in Serum Creatinine Level as a Meaningful End Point in Randomized Clinical Trials. J Am Soc Nephrol [Internet]. 2016 Aug;27(8):2529–42. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26712525 | eng |
| dcterms.references | Gómez-Carracedo A, Arias-Muñana E, Jiménez-Rojas C. Enfermedad renal crónica - Progesión de la IRC. Nefrol al dia. 2016;36(1):[48-55]. | spa |
| dcterms.references | López CAN. Predicción de progresión de enfermedad renal crónica en pacientes diabéticos por la fórmula Kidney Failure Risk Equation (KFRE) en población mexicana. Tecnologico de Monterrey. 2 Instituto Tecnológico y de Estudios Superiores de Monterrey Escuela de Medicina y Ciencias de la Salud; 2020. | spa |
| dcterms.references | Bhachu HK, Fenton A, Cockwell P, Aiyegbusi O, Kyte D, Calvert M. Use of the kidney failure risk equation to inform clinical care of patients with chronic kidney disease: a mixed-methods systematic review. BMJ Open. 2022 Jan;12(1):e055572. | eng |
| dcterms.references | Carrero JJ, Hecking M, Chesnaye NC, Jager KJ. Sex and gender disparities in the epidemiology and outcomes of chronic kidney disease. Nat Rev Nephrol. 2018 Mar;14(3):151–64 | eng |
| dcterms.references | Kovesdy CP. Epidemiology of chronic kidney disease: an update 2022. Kidney Int Suppl. 2022 Apr;12(1):7–11. | eng |
| dcterms.references | Lewandowski MJ, Krenn S, Kurnikowski A, Bretschneider P, Sattler M, Schwaiger E, et al. Chronic kidney disease is more prevalent among women but more men than women are under nephrological care : Analysis from six outpatient clinics in Austria 2019. Wien Klin Wochenschr. 2023 Feb;135(3– 4):89–96. | eng |
| dcterms.references | Mallappallil M, Friedman EA, Delano BG, McFarlane SI, Salifu MO. Chronic kidney disease in the elderly: evaluation and management. Clin Pract (Lond). 2014;11(5):525–35. | eng |
| dcterms.references | Hamrahian SM, Falkner B. Hypertension in Chronic Kidney Disease. Adv Exp Med Biol. 2017;956:307–25. | eng |
| dcterms.references | Georgianos PI, Agarwal R. Hypertension in chronic kidney disease—treatment standard 2023. Nephrol Dial Transplant. 2023 Jun; | eng |
| dcterms.references | Abraham HMA, White CM, White WB. The comparative efficacy and safety of the angiotensin receptor blockers in the management of hypertension and other cardiovascular diseases. Drug Saf. 2015 Jan;38(1):33–54. | eng |
| dcterms.references | Bravo-Zúñiga J, Saldarriaga EM, Chávez-Gómez R, Gálvez-Inga J, Valdivia-Vega R, Villavicencio-Carranza M, et al. Effectiveness of adherence to a renal health program in a health network in Peru. Rev Saude Publica. 2020 Aug;54:80. | eng |
| dcterms.references | Li PK-T, Garcia-Garcia G, Lui S-F, Andreoli S, Fung WW-S, Hradsky A, et al. Kidney health for everyone everywhere - from prevention to detection and equitable access to care. Brazilian J Med Biol Res = Rev Bras Pesqui medicas e Biol. 2020;53(3):e9614. | eng |
| dcterms.references | Kattah AG, Garovic VD. Understanding sex differences in progression and prognosis of chronic kidney disease. Ann Transl Med. 2020 Jul;8(14):897. | eng |
| dcterms.references | Prasad R, Jha RK, Keerti A. Chronic Kidney Disease: Its Relationship With Obesity. Cureus. 2022 Oct;14(10):e30535. | eng |
| dcterms.references | Bello AK, Alrukhaimi M, Ashuntantang GE, Basnet S, Rotter RC, Douthat WG, et al. Complications of chronic kidney disease: current state, knowledge gaps, and strategy for action. Kidney Int Suppl. 2017 Oct;7(2):122–9. | eng |
| dcterms.references | Abcar AC, Chan L, Yeoh H. What To Do for the Patient with Minimally Elevated Creatinine Level? Perm J. 2004;8(1):51–3. | eng |
| dcterms.references | O’Seaghdha CM. A Risk Score for Chronic Kidney Disease in the General Population. HHS Author Manuscripts. 2013; | eng |
| dcterms.references | Kamath CC, Dobler CC, Lampman MA, Erwin PJ, Matulis J, Elrashidi M, et al. Implementation strategies for interventions to improve the management of chronic kidney disease (CKD) by primary care clinicians: protocol for a systematic review. BMJ Open. 2019 Aug;9(8):e027206. | eng |
| dcterms.references | Ameh OI, Ekrikpo U, Bello A, Okpechi I. Current Management Strategies of Chronic Kidney Disease in Resource-Limited Countries. Int J Nephrol Renovasc Dis. 2020;13:239–51. | eng |
| dcterms.references | García GG, Iyengar A, Kaze F, Kierans C, Padilla-Altamira C, Luyckx VA. Sex and gender differences in chronic kidney disease and access to care around the globe. Semin Nephrol. 2022 Mar;42(2):101–13. | eng |
| oaire.version | info:eu-repo/semantics/acceptedVersion | spa |
| sb.programa | Especialización en Nefrología | spa |
| sb.sede | Sede Barranquilla | spa |